21 October 2021
A multidisciplinary committee has been appointed to plan the Third International Summit on Human Genome Editing, which will take place 6-8 March 2023 in London, UK. The committee, which includes representatives from eleven nations, is being chaired by Professor Robin Lovell-Badge FMedSci FRS.
The three-day Summit will be held at The Francis Crick Institute in London, with the option to participate remotely. The Summit is being organised by the UK Royal Society and Academy of Medical Sciences, the US National Academies of Sciences and Medicine and UNESCO-The World Academy of Sciences for the advancement of science in developing countries (TWAS). It will build on previous events held in Washington, D.C. (2015), and Hong Kong (2018) and continue important international dialogue around human genome editing.
During the Summit, international stakeholders representing the academic, medical, regulatory, bioethical, and patient communities will discuss global considerations regarding human genome editing, including:
Visit the Summit’s event page for more information and updates. Please use and follow #HGESummit on social media.
Robin Lovell-Badge1 2 (Chair)
Group Leader, Stem Cell Biology and Developmental Genetics,
The Francis Crick Institute, UK
David Baltimore3 4 5
President Emeritus and Distinguished Professor of Biology,
The California Institute of Technology, USA
Françoise Baylis
University Research Professor, Philosophy,
Dalhousie University, Canada
Ewan Birney1 2
Deputy Director General of EMBL & Director of EMBL-EBI,
The European Bioinformatics Institute, UK
Alta Charo4
Warren P. Knowles Professor Emerita of Law and Bioethics,
University of Wisconsin-Madison, USA
George Daley4
Dean of the Faculty of Medicine and Caroline Shields Walker Professor of Medicine,
Harvard Medical School, USA
Javier Guzman
Director of Global Health Policy,
Center for Global Development, USA
Daria Julkowska
Scientific Coordinator of the European Joint Programme on Rare Disease,
Thematic Institute of Genetics & European Joint Programme on Rare Disease, France
Julie Makani
Associate Professor in the Department of Haematology and Blood Transfusion,
Muhimbili University of Health and Allied Sciences, Tanzania
Chris McCabe
Executive Director and CEO,
Institute of Health Economics, Canada
Luigi Naldini
Professor of Cell and Tissue Biology and of Gene and Cell Therapy & Scientific Director of the San Raffaele Telethon Institute for Gene Therapy,
San Raffaele University School of Medicine, Italy
Cor Oosterwijk
Managing Director,
VSOP (Association of Cooperating Parent and Patient Organisations), The Netherlands
Lily Paemka
Lecturer, Coordinator Genetics Program & Principal Investigator,
University of Ghana, Ghana
Michèle Ramsay
Director of the Wits Sydney Brenner Institute for Molecular Bioscience (SBIMB), Professor in Human Genetics and South African Research Chair in Genomics and Bioinformatics of African Populations,
The University of the Witwatersrand, South Africa
Elisa Reis
Professor of Political Sociology & Chair of the Interdisciplinary Research Network for the Study of Social Inequality,
Federal University of Rio de Janeiro, Brazil
Haoyi Wang
Principal Investigator, State Key Laboratory of Stem Cell and Reproductive Biology,
Institute of Zoology, Chinese Academy of Sciences, China
Mayana Zatz6
Professor and Founder of the Brazilian Association of Muscular Dystrophy,
University of São Paulo, Brazil
1 Fellow, The Royal Society
2 Fellow, The Academy of Medical Sciences
3 Member, U.S. National Academy of Sciences
4 Member, U.S. National Academy of Medicine
5 Foreign Member, The Royal Society
6 Fellow, The World Academy of Sciences
Note: Jennifer Doudna3 4 5 (Li Ka Shing Chancellor's Chair Professor in the Department of Chemistry and the Department of Molecular and Cell Biology, University of California, Berkeley, USA) was an active member only from April 2021 - May 2022